Whitehawk Therapeutics (WHWK) Receivables - Net (2022 - 2024)
Whitehawk Therapeutics (WHWK) has disclosed Receivables - Net for 3 consecutive years, with $5.9 million as the latest value for Q4 2024.
- On a quarterly basis, Receivables - Net rose 7.56% to $5.9 million in Q4 2024 year-over-year; TTM through Dec 2024 was $5.9 million, a 7.56% increase, with the full-year FY2024 number at $5.9 million, up 7.56% from a year prior.
- Receivables - Net was $5.9 million for Q4 2024 at Whitehawk Therapeutics, down from $6.5 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $6.5 million in Q3 2024 to a low of $1.9 million in Q4 2022.
- A 3-year average of $4.4 million and a median of $5.2 million in 2023 define the central range for Receivables - Net.
- Peak YoY movement for Receivables - Net: soared 194.74% in 2023, then fell 11.36% in 2024.
- Whitehawk Therapeutics' Receivables - Net stood at $1.9 million in 2022, then skyrocketed by 194.74% to $5.5 million in 2023, then increased by 7.56% to $5.9 million in 2024.
- Per Business Quant, the three most recent readings for WHWK's Receivables - Net are $5.9 million (Q4 2024), $6.5 million (Q3 2024), and $5.9 million (Q2 2024).